Zdrowie i gospodarka · 17/02/1999

FDA Releases Guidance for Industry on Clinical Development Programs for Rheumatoid Arthritis Treatment

The FDA has made available a guidance document to help pharmaceutical and medical device companies develop clinical trials for treatments of rheumatoid arthritis (RA), outlining the types of claims that can be made and the necessary trial designs.